Sign in
Fluorescein Angiography Findings Post-intravitreal Bevacizumab for ROP: Can It Predict the Late-Onset Risk of Recurrence?
Swati Agarwal-Sinha, MD, FASRS
Annual Meeting Talks
2018
Anti-VEGF/Anti-Angiopoietin-2 Bispecific Antibody RG7716 in Diabetic Macular Edema: 36-Week Results From the Phase 2 BOULEVARD Clinical Trial
Rishi P. Singh, MD
Heads-Free!: 3D Head-Mounted Display System for Vitreoretinal Surgery
Murat Oncel, MD, FASRS
Category: Ocular Oncology